Loading company…
Bangalore biotech developing AI-based prognostic tests, led by CanAssist Breast, to assess breast cancer recurrence risk.
Founded in 2011 in Bangalore, India, by Manjiri Bakre, OncoStem Diagnostics Pvt. Ltd. develops prognostic tests that assess tumor aggressiveness and cancer recurrence risk, mainly for breast cancer. Its flagship CanAssist Breast uses an AI-based statistical model to classify patients as low-risk or high-risk, and it serves over 300 oncologists across South Asia. A Series A round of USD 6 mn was led by Sequoia Capital in September 2017, and the company reported 2023 revenue of USD 703,455.20.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in